Original work
Long-lasting molecular remission as a precondition for successful pregnancy in female patients with chronic myeloid leukemia
MUDr. Katarína Slezáková, PhD., MUDr. Lucia Setteyová, RNDr. Miroslava Eckertová, PhD.
Introduction: In the era of tyrosine kinase inhibitors (TKI), treatment of patients with chronic myeloid leukemia (CML) during pregnancy represents an important clinical challenge not only...
Keywords: chronic myeloid leukemia, molecular response, pregnancy, tyrosine kinase inhibitors
newslab 2016, 2 : 109
